Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
MRNA
TEVA
Add up to 3 more stocks
MRNA
Moderna, Inc.
-1.29%
$148.87-1.94Delayed quote: Sep 3, 2026, 4:00 PM EDT
Market Cap
$59.07B
52W Range
$22.28 - $176.66
TEVA
Teva Pharmaceutical Industries Limited
-2.34%
$36.61-0.88Delayed quote: Sep 3, 2026, 3:59 PM EDT
Market Cap
$42.64B
52W Range
$18.21 - $38.37
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 62.48 |
| Forward P/E | N/A | 18.74 |
| P/B Ratio | 8.83 | 5.71 |
| P/S Ratio | 26.80 | 2.56 |
| P/FCF Ratio | N/A | 32.85 |
| EV/EBITDA | N/A | 19.35 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 55.4% | 52.5% |
| Operating Margin | -158.1% | 11.4% |
| Net Margin | -141.4% | 4.1% |
| ROE | -46.6% | 9.1% |
| ROA | -28.8% | 1.8% |
| ROIC | -39.2% | 6.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.29 | 0.88 |
| Quick Ratio | 2.18 | 0.67 |
| Debt/Equity | 0.19 | 2.18 |
| Interest Coverage | -307.40 | 2.35 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes metrics that are structurally not meaningful for a company's sector (e.g. EV multiples, free-cash-flow ratios, and working-capital ratios for banks and insurers). Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.